Legislation that would reauthorize user fee programs for medical devices, pharmaceuticals, generic drugs and biosimilars has cleared the House Energy and Commerce health subcommittee. The panel has agreed to all four amendments of the bill, including provisions for over-the-counter hearing aids and improvements on the medical device inspection process.
User fee reauthorization bill clears House subcommittee
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.